Literature DB >> 9039084

Hypoxia stimulates atrial natriuretic peptide gene expression in cultured atrial cardiocytes.

Y F Chen1, J Durand, W C Claycomb.   

Abstract

The current study tested the hypothesis that hypoxia stimulates atrial natriuretic peptide (ANP) gene expression and secretion in cultured atrial myocytes (AT-1 cells). AT-1 cells were obtained from a transplantable mouse atrial cardiomyocyte tumor lineage. Confluent AT-1 cells were exposed to hypoxia (1% oxygen) or normoxia (21% oxygen) as controls for 6 hours to 7 days. Medium ANP levels were measured by radioimmunoassay, and intracellular ANP gene transcripts were quantified by Northern and slot blot analyses. Exposure to hypoxia resulted in a significant increase in cellular ANP mRNA levels within 36 hours, which peaked (3.6-fold increase) at 2 days after hypoxic exposure, and produced a time-dependent increase in the release of ANP from AT-1 cells for 2 to 7 days. Transfection studies with recombinant DNA constructs that contained fragments of the -3003/+62 sequence of the ANP promoter and the luciferase reporter gene revealed that the regulatory sequences that mediate the hypoxia-induced increase in transcription are located within a region that extends from -638 to -518 bp to the transcriptional start site of the ANP gene. Gel mobility shift assays demonstrated that hypoxia-inducible nuclear proteins that bound to the 120-bp putative hypoxia-responsive elements of the ANP gene were produced during hypoxic exposure. We have thus defined a 120-bp region within the ANP gene promoter that contains hypoxia-responsive elements that might be responsible for the enhancement of ANP gene expression in atrial myocytes during hypoxic exposure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9039084     DOI: 10.1161/01.hyp.29.1.75

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  Relation of natriuretic peptide concentrations to central sleep apnea in patients with heart failure.

Authors:  Andrew D Calvin; Virend K Somers; Christelle van der Walt; Christopher G Scott; Lyle J Olson
Journal:  Chest       Date:  2011-06-02       Impact factor: 9.410

2.  Transforming growth factor-β inhibits myocardial PPARγ expression in pressure overload-induced cardiac fibrosis and remodeling in mice.

Authors:  Kaizheng Gong; Yiu-Fai Chen; Peng Li; Jason A Lucas; Fadi G Hage; Qinglin Yang; Susan E Nozell; Suzanne Oparil; Dongqi Xing
Journal:  J Hypertens       Date:  2011-09       Impact factor: 4.844

3.  Hypoxic activation of the atrial natriuretic peptide gene promoter through direct and indirect actions of hypoxia-inducible factor-1.

Authors:  Yang-Sook Chun; Ju-Yeon Hyun; Yong-Geun Kwak; In-San Kim; Chan-Hyung Kim; Eunjoo Choi; Myung-Suk Kim; Jong-Wan Park
Journal:  Biochem J       Date:  2003-02-15       Impact factor: 3.857

4.  Hypoxia increases the release of salmon cardiac peptide (sCP) from the heart of rainbow trout (Oncorhynchus mykiss) under constant mechanical load in vitro.

Authors:  Olli Arjamaa; Olli Vuolteenaho; Elina Kivi; Mikko Nikinmaa
Journal:  Fish Physiol Biochem       Date:  2013-06-29       Impact factor: 2.794

5.  Mid-regional pro-atrial natriuretic peptide independently predicts short-term mortality in COVID-19.

Authors:  Christoph C Kaufmann; Amro Ahmed; Mona Kassem; Matthias K Freynhofer; Bernhard Jäger; Gabriele Aicher; Susanne Equiluz-Bruck; Alexander O Spiel; Georg-Christian Funk; Michael Gschwantler; Peter Fasching; Johann Wojta; Kurt Huber
Journal:  Eur J Clin Invest       Date:  2021-03-10       Impact factor: 5.722

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.